Meiji and LB Bulgaricum Collaborate on Groundbreaking Yogurt Research in Bulgaria
The research will take place with LB Bulgaricum, a Bulgarian company that produces yogurt, milk, cheese, and butter. LB Bulgaricum also sells probiotic supplements named Proway.
The agreement entails the establishment of a new research center in Sofia, Bulgaria. This center will focus on studying lactic acid bacteria, developing a new yogurt starter, and collecting microorganisms from Bulgaria.
Meiji Company emphasized the study of Bulgarian yogurt, inspired by Ilya Mechnikov’s research. Mechnikov won the Nobel Prize for his work in physiology and medicine. He believed that a healthy gut microbiome, supported by friendly bacteria in yogurt, could enhance health and delay aging.
Yoshie Kogawa from Meiji stated, “Meiji is interested in the connection between gut microbiota and longevity… We are exploring the health benefits of Bulgarian yogurt.” Mechnikov claimed that daily intake of probiotics from yogurt could improve health.
Meiji is particularly interested in how gut health affects lifespan and quality of life. Recent studies show that gut microbiota can influence health through immune support and reducing inflammation. A healthy gut is linked to better living conditions and longevity.
How does the partnership between LB Bulgaricum and Meiji Company enhance research on probiotics?
Interview with Dr. Elena Ivanova, Lead Scientist at LB Bulgaricum
News Directory 3: Thank you for joining us today, Dr. Ivanova. Let’s dive right into the exciting new research collaboration between LB Bulgaricum and Meiji Company. Can you tell us about the goals of the new research center in Sofia?
Dr. Elena Ivanova: Thank you for having me. The primary aim of our new research center is to deepen our understanding of lactic acid bacteria, with a focus on our unique Bulgarian yogurt strains. We intend to develop a new yogurt starter that leverages our rich biodiversity of microorganisms. Additionally, we want to collect and study various microorganisms endemic to Bulgaria, which could potentially have significant health benefits.
News Directory 3: It’s fascinating to see this emphasis on traditional Bulgarian yogurt. How does Ilya Mechnikov’s research influence your current projects?
Dr. Elena Ivanova: Ilya Mechnikov’s pioneering work is indeed a cornerstone for our research. He proposed that a diet rich in probiotics could promote gut health and longevity. His theories laid the foundation for what we now understand about the gut microbiome’s impact on overall health. Our collaboration with Meiji is a natural progression of his legacy, as we explore how our traditional yogurt can contribute to health and possibly even delay aging.
News Directory 3: In the context of gut health, what specific benefits do you anticipate from the strains of Lactobacillus delbrueckii ssp. bulgaricus you are studying?
Dr. Elena Ivanova: Research indicates that this specific strain has several potential health benefits, including the reduction of respiratory infection symptoms and alleviating summer fatigue. We are particularly excited about its immune-supporting properties, as well as its capability to reduce inflammation, which can contribute to healthier lifestyles and longevity.
News Directory 3: Yoshie Kogawa from Meiji highlighted the importance of understanding gut microbiota in relation to longevity. How will this research contribute to that understanding?
Dr. Elena Ivanova: Our collaborative research will analyze how the unique properties of Bulgarian yogurt correlate with gut health and longevity. We aim to generate data that elucidates these relationships further. By integrating science with traditional practices, we hope to identify how our yogurt can support the immune system and improve overall quality of life.
News Directory 3: What does the future hold for new yogurt products coming from this partnership? Are there any projected timelines for development or market launch?
Dr. Elena Ivanova: While we are enthusiastic about developing innovative yogurt products, we are still in the preliminary research stages. This means we are focusing on studying flavors and properties before finalizing any products. Therefore, specific timelines for development and market launch remain uncertain, but we are committed to maintaining high standards of quality and health benefits derived from our research.
News Directory 3: Last question, Dr. Ivanova. How has the partnership with Meiji evolved over the years, and what do you see as the next steps?
Dr. Elena Ivanova: Our partnership with Meiji spans over 50 years, beginning at the Osaka Expo in 1970 and leading to the production of Meiji Bulgaria Yogurt. This long-standing collaboration has strengthened our shared commitment to probiotics and the health benefits of yogurt. The next steps involve deepening our joint research efforts and continuing to build on the scientific foundations laid by Mechnikov. We are excited about where this journey will lead us in the realm of health and nutrition.
News Directory 3: Thank you, Dr. Ivanova, for sharing these insights with us. We look forward to seeing the outcomes of your research.
Dr. Elena Ivanova: Thank you for having me; it’s been a pleasure to discuss our exciting projects!
The company has researched Lactobacillus delbrueckii ssp. Bulgaricus. Some findings suggest that yogurt with the strain can reduce respiratory infection symptoms. Other research indicates it may help with summer fatigue.
The joint research aims to create new yogurt products. However, specific timelines for development and market launch remain undecided. The process will consider the flavors and properties of yogurt.
This new research builds on over 50 years of cooperation between Meiji and Bulgarian yogurt. Their journey began in 1970 during the Osaka Expo, leading to the launch of Meiji Bulgaria Yogurt in 1973, produced under a license from LB Bulgaricum.